Jump to content

Christine Alewine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Monkbot (talk | contribs) at 06:22, 26 November 2020 (Task 18 (cosmetic): eval 6 templates: del empty params (1×); cvt lang vals (1×);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Christine Alewine
Born
Christine K. Campo
Alma materDartmouth College (BA)
University of Maryland School of Medicine (MD, PhD)
Children2
Scientific career
FieldsOncology, biology
InstitutionsNational Cancer Institute
ThesisPDZ protein regulation of Kir 2.3 (2006)

Christine Campo Alewine is an American oncologist and biologist researching immunotoxin therapeutics in pancreatic cancer. She is an investigator at the National Cancer Institute.

Education

Campo completed a B.A. in chemistry and Asian studies at Dartmouth College. In college, she interned under chemist Karen Wetterhahn focusing on the environmental effects of toxic metals. It was in this lab that Alewine was introduced to MD–PhD programs and became interested in becoming a physician-scientist. She completed a postbaccalaureate program at the National Cancer Institute's laboratory of pathology from 1998 to 1999.[1] Campo earned a M.D. and Ph.D. from the University of Maryland School of Medicine.[2] Her dissertation in 2006 was titled, PDZ protein regulation of Kir 2.3.[3] She completed internal medicine residency in the Osler Medical Training Program at Johns Hopkins Hospital followed by clinical fellowship in medical oncology at NCI.[2] 

Career and research

She joined NCI's laboratory of molecular biology as an assistant clinical investigator through the support of the clinical investigator development program in 2014 and became a tenure-track investigator through the NIH Lasker Scholar program in 2016.[4] Alewine researches the use of immunotoxin therapeutics in pancreatic cancer.[5] Her lab and clinic are testing and refining two recombinant immunotoxins that target a protein called mesothelin that is present on the surface of several types of cancer tumor cells, including pancreatic, ovarian, and some lung cancers.[6]

Personal life

Alewine is married with two daughters.[1]

References

  1. ^ a b "Lasker Clinical Research Scholars". NIH Intramural Research Program. 2017-02-27. Retrieved 2020-07-21.Public Domain This article incorporates text from this source, which is in the public domain.
  2. ^ a b "Principal Investigators". NIH Intramural Research Program. Retrieved 2020-07-21.Public Domain This article incorporates text from this source, which is in the public domain.
  3. ^ Campo, Christine K. (2006). PDZ protein regulation of Kir 2.3 (PhD thesis). University of Maryland, Baltimore. OCLC 77637455.
  4. ^ "Principal Investigators". NIH Intramural Research Program. Retrieved 2020-07-21.Public Domain This article incorporates text from this source, which is in the public domain.
  5. ^ "Christine Campo Alewine, M.D., Ph.D." Center for Cancer Research. 2014-08-12. Retrieved 2020-07-21.Public Domain This article incorporates text from this source, which is in the public domain.
  6. ^ "Dr. Christine Alewine — Treating Pancreatic Cancer with New Immunotoxin Strategies". NIH Intramural Research Program. 2019-02-04. Retrieved 2020-07-21.Public Domain This article incorporates text from this source, which is in the public domain.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Christine_Alewine&oldid=990737191"